Choline
Drug profile
Also known as: bilineurine, choline bitartrate, choline chloride, choline ion, vitamin J
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Choline is an ofp drug catalogued in DrugCentral. DrugCentral lists 8 molecular targets, including Slc5a7, Chrna2|Chrnb2 and Chrna4|Chrnb4. Recorded indications include Insomnia.
- Approval status: ofp.
- Molecular targets: Slc5a7, Chrna2|Chrnb2, Chrna4|Chrnb4 and Chrna3|Chrnb2 (8 listed in DrugCentral).
- Indications: Insomnia.
- Molecular formula: C5H14NO; molecular weight 104.17 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (1)
- Insomnia
Mechanism & targets
Molecular targets (8)
| Target | Gene | Action | Activity |
|---|---|---|---|
| High affinity choline transporter 1 | Slc5a7 | unknown | IC50 5.80 |
| Neuronal acetylcholine receptor; alpha2/beta2 | Chrna2|Chrnb2 | unknown | Ki 4.74 |
| Neuronal acetylcholine receptor; alpha4/beta4 | Chrna4|Chrnb4 | unknown | Ki 4.47 |
| Neuronal acetylcholine receptor; alpha3/beta2 | Chrna3|Chrnb2 | unknown | Ki 4.43 |
| Neuronal acetylcholine receptor; alpha4/beta2 | Chrna4|Chrnb2 | unknown | Ki 4.43 |
| Creatine transporter | Slc6a8 | unknown | Ki 4.38 |
| Acetylcholine receptor subunit delta | chrnd | unknown | Ki 4.38 |
| Neuronal acetylcholine receptor; alpha3/beta4 | Chrna3|Chrnb4 | unknown | Ki 4.32 |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | FDA | — | — |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Off label use | 223.8 |
| Product use in unapproved indication | 201.0 |
| Diarrhoea | 172.9 |
| Product dose omission issue | 164.3 |
| Contraindicated product administered | 162.7 |
| Synovitis | 162.3 |
| Fall | 143.6 |
| Systemic lupus erythematosus | 142.4 |
| Treatment failure | 135.0 |
| Fatigue | 126.6 |
| Glossodynia | 120.4 |
| Infusion related reaction | 115.2 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Choline is on its molecule page.
| Molecular formula | C5H14NO |
|---|---|
| Molecular weight | 104.17 g/mol |
| CAS number | 62-49-7 |
| InChIKey | OEYIOHPDSNJKLS-UHFFFAOYSA-N |
| PubChem CID | 305 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Choline used for?
DrugCentral lists the following indications for Choline: Insomnia.
How does Choline work?
Its molecular targets in DrugCentral include Slc5a7, Chrna2|Chrnb2, Chrna4|Chrnb4 and Chrna3|Chrnb2.
What is the chemical formula of Choline?
Choline has the molecular formula C5H14NO and a molecular weight of 104.17 g/mol.
Browse: all drugs starting with C · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 3097 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL2105935 — compound record and bioactivity
- PubChem CID 305 — chemical identifiers
- DrugBank DB00122 — drug record
- FDA UNII N91BDP6H0X — substance identity
- DailyMed: FDA labels for Choline — current prescribing information (label search)
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.